INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

21,251 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$35K
52 sh
Page 219 of 532
← PrevNext →
Jun 23, 2026
Jun 25, 2026
traded Jun 23, 2026
+2d
SEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$17K
26 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$48K
70 sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$8,931
13 sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
39 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$17K
26 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

12
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$472K
16.3K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

12
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$472K
16.3K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

12
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$448K
15.5K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

11
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$19K
1,258 sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

11
WL
Williams William L. IiiDirector
LOBLive Oak Bancshares, Inc.
Open-market sale · 10b5-1 plan
SELL$336K
8,400 sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

10
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$2,919
97 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

10
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$3,069
102 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

10
KJ
Knopp Kevin J.Director, President and CEO
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$31K
3,422 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

10
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$3,069
102 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

9
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$108K
5,394 sh
Jun 25, 2026Jun 25, 2026
traded Jun 25, 2026
+0dSEC Form 4

Evidence

9
KJ
Knopp Kevin J.Director, President and CEO
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$149K
16.4K sh
Jun 25, 2026Jun 25, 2026
traded Jun 25, 2026
+0dSEC Form 4

Evidence

6
BD
Brown Christopher D.Director
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$89K
9,900 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

1
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$54K
1,799 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

0
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$9,929
1,100 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

0
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
1,450 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

57
PR
Petkovich Jacob RPresident - Marine
PATKPATRICK INDUSTRIES INC
Open-market purchase
BUY$124K
1,300 sh
May 6, 2026Jun 24, 2026
traded May 6, 2026
+49dSEC Form 4

Evidence

55
BM
Beaulier Jonathan MeadChief Revenue Officer
SNOWSnowflake Inc.
Open-market sale
SELL$2.17M
9,367 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC Form 4

Evidence

49
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$77K
3,329 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC Form 4

Evidence

46
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$35K
1,583 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC Form 4

Evidence

46
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$23K
1,118 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC Form 4

Evidence

46
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$36K
1,797 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC Form 4

Evidence

45
SC
Stephenson Brian CChief Financial Officer
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$165K
6,836 sh
Jun 23, 2026Jun 24, 2026
traded Jun 23, 2026
+1dSEC Form 4

Evidence

39
SV
Sosa VeronicaChief Accounting Officer
ASANAsana, Inc.
Open-market sale
SELL$76K
11.4K sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC Form 4

Evidence

39
Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$1.53M
6,666 sh
Jun 23, 2026Jun 24, 2026
traded Jun 23, 2026
+1dSEC Form 4

Evidence

39
RM
Rogers Daniel MarkDirector, Chief Executive Officer
ASANAsana, Inc.
Open-market sale
SELL$180K
27.0K sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC Form 4

Evidence

39
Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$2.55M
11.3K sh
Jun 24, 2026Jun 24, 2026
traded Jun 24, 2026
+0dSEC Form 4

Evidence

39
Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$1.75M
7,731 sh
Jun 24, 2026Jun 24, 2026
traded Jun 24, 2026
+0dSEC Form 4

Evidence

37
JN
Joseph NelsonPFO, PAO & Treasurer
CCIFCarlyle Credit Income Fund
Open-market purchase
BUY$5,460
2,000 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC Form 4

Evidence

37
PK
Parikh Anand KiranDirector, President and CEO
FTHFaeth Therapeutics, Inc.
Open-market purchase
BUY$55K
2,806 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC Form 4

Evidence

36
Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$407K
1,818 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC Form 4

Evidence

36
BJ
Bers JenniferChief Revenue Officer
ARQQArqit Quantum Inc.
Open-market sale
SELL$178K
8,288 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC Form 4

Evidence

36
TM
Tyler Lauren MDirector
CORCencora, Inc.
Open-market purchase
BUY$149K
550 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC Form 4

Evidence

36
Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$335K
1,475 sh
Jun 24, 2026Jun 24, 2026
traded Jun 24, 2026
+0dSEC Form 4

Evidence

36
Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$640K
2,868 sh
Jun 22, 2026Jun 24, 2026
traded Jun 22, 2026
+2dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K